Plasminogen activators, activation inhibitors and alpha 2-macroglobulin produced by cultured normal and malignant human cells
- PMID: 6202645
- DOI: 10.1002/ijc.2910330510
Plasminogen activators, activation inhibitors and alpha 2-macroglobulin produced by cultured normal and malignant human cells
Abstract
In the present paper we have characterized the plasminogen activators (PA) synthesized by 25 different human cell lines. Technically easy methods were adopted for concentration and immunological characterization of the activators even in the presence of PA inhibitors. Most cell lines produced u-PA (mol. wt 55,000), melanoma and HeLa cells t-PA (mol. wt 66,000) and two carcinoma cell lines and normal skin fibroblasts produced no detectable PA. The classical 125I-fibrin method was compared to a caseinolytic assay and some of the discrepancies between results obtained with the two methods were shown to be due to cell-derived NaDodSO4-sensitive proteinase inhibitors in culture media. Additionally, synthesis and uptake by the cells of the wide-spectrum proteinase inhibitor alpha-2-macroglobulin ( alpha 2M ) were studied by radioimmunoassay and immunofluorescence. No production of alpha 2M could be measured in any of the malignant cell lines. In normal cells no correlation existed between the production of alpha 2M and the observed inhibition of PA activity, which indicates that other proteinase inhibitors are produced by the cells.
Similar articles
-
Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.Cell Regul. 1990 Nov;1(12):895-905. doi: 10.1091/mbc.1.12.895. Cell Regul. 1990. PMID: 1712633 Free PMC article.
-
Regulation of plasminogen activator activity in human fibroblastic cells by fibrosarcoma cell-derived factors.Cancer Res. 1985 May;45(5):2314-9. Cancer Res. 1985. PMID: 3921241
-
Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.Biochim Biophys Acta. 1984 Nov 6;802(1):99-110. doi: 10.1016/0304-4165(84)90039-4. Biochim Biophys Acta. 1984. PMID: 6435688
-
Plasminogen activation and regulation of pericellular proteolysis.Biochim Biophys Acta. 1985 Nov 12;823(1):35-65. doi: 10.1016/0304-419x(85)90014-9. Biochim Biophys Acta. 1985. PMID: 2413894 Review. No abstract available.
-
[Immunological background of plasma protein abnormalities--the relation between inflammation and malignant neoplasm].Rinsho Byori. 1999 Oct;47(10):909-16. Rinsho Byori. 1999. PMID: 10590664 Review. Japanese.
Cited by
-
Localization of alpha 2-macroglobulin in human primary sarcomas and synthesis in established cell lines.In Vitro Cell Dev Biol. 1988 May;24(5):369-72. doi: 10.1007/BF02628487. In Vitro Cell Dev Biol. 1988. PMID: 2453500
-
Serum levels of some acute phase proteins in kidney and urinary tract urothelial cancers.Int Urol Nephrol. 1997;29(4):427-32. doi: 10.1007/BF02551108. Int Urol Nephrol. 1997. PMID: 9405999
-
Studies on rat mammary adenocarcinomas: a model for metastasis.Cancer Metastasis Rev. 1985;4(3):195-208. doi: 10.1007/BF00048095. Cancer Metastasis Rev. 1985. PMID: 3907819 Review.
-
Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids.EMBO J. 1986 Sep;5(9):2217-22. doi: 10.1002/j.1460-2075.1986.tb04487.x. EMBO J. 1986. PMID: 3780677 Free PMC article.
-
Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.Br J Exp Pathol. 1988 Oct;69(5):685-95. Br J Exp Pathol. 1988. PMID: 3143395 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous